The associate professor of neurology at the Icahn School of Medicine at Mount Sinai talked about the major biomarkers used to track progression in Huntington disease. [WATCH TIME: 5 minutes]
Sarah O'Shea, MD, MSc
Advertisement
Associate professor of neurology at the Icahn School of Medicine at Mount Sinai.
Articles by Sarah O'Shea, MD, MSc
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1
Early Results Show Symptom Gains in First Patient Dosed With UX-DA001 Cell Therapy for Parkinson Disease
2
Mechanistic Rationale Behind Amlenetug to Treat Multiple System Atrophy: Johan Luthman, PhD
3
Testing D1 Receptor Modulator Glovadalen in Phase 2 Trial for Parkinson Disease: Milton Biagioni MD, CMD
4
Using Brain Stimulation to Curb Cannabis Overuse in Multiple Sclerosis
5
